|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and more than 2,300 generic ingredients from more than 1,700 branded and generic pharmaceutical companies, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Generic Name: methylphenidate
Summary for Generic Name: methylphenidate
|
Tentative approvals for METHYLPHENIDATE
| ||||||||||||||||||||||
Clinical Trials for: methylphenidateA Study to Explore Plasma Levels of CONCERTA, Ritalin-SR and Novo-Methylphenidate ER-C in Healthy Volunteers Status: Completed Condition: Pharmacokinetics Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning Status: Terminated Condition: Brain Tumor A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV Status: Recruiting Condition: HIV Dementia Methylphenidate Study in Breast or Gastrointestinal Cancer Patients Status: Active, not recruiting Condition: Breast Cancer; Fatigue; Gastrointestinal Cancer Ritalin: Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patients Status: Terminated Condition: Asthenia; Neoplasms An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder Status: Completed Condition: Attention Deficit Hyperactivity Disorder Courtesy of ClinicalTrials.org See more clinical trials for this drug | |||||||||||||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Patented / Exclusive Use | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | RITALIN | methylphenidate hydrochloride | TABLET; ORAL | 010187 | Approved Prior to Jan 1, 1982 | RX | No | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Novartis | RITALIN | methylphenidate hydrochloride | TABLET; ORAL | 010187 | Approved Prior to Jan 1, 1982 | RX | Yes | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Watson Labs | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET; ORAL | 040220 | Aug 29, 1997 | RX | No | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ucb Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET; ORAL | 086429 | Approved Prior to Jan 1, 1982 | RX | No | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc